THC <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Acquires Iconic Oregon Cannabis Brand SugarTop Buddery in $3M All-Share Deal
THC Therapeutics, Inc. has announced its acquisition of SugarTop Buddery, a prominent cannabis brand based in Eugene, Oregon. The transaction, valued at approximately $3 million, was completed through the issuance of newly created Series D Preferred stock. This acquisition enhances THCT's presence in Oregon and supports its strategy to establish a bi-coastal, vertically integrated national cannabis platform. Anna Kaplan, CEO of SugarTop Buddery, expressed optimism about the growth opportunities and the ability to engage new markets on the East Coast. This marks THCT's second strategic acquisition, following its recent purchase of The Headquarters Group. SugarTop Buddery, founded in 2015, is celebrated for its community-driven and music-inspired approach to cannabis, emphasizing artistry, equity, and sustainability.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. THC Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001477932-25-005094), on July 17, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.